REM sleep behavior disorder is a condition in which a person acts out dreams during his or her sleep...understandingly, it can be dangerous for that person's bed partner!
What is important to know, is that there is a link between this disorder and Parkinson's disease. So anything you can do to discourage the nervous system from progressing in this direction can be crucial.
Researchers recently reported that a variety of medications can be helpful in treating REM sleep disorder, especially clonazepam (Klonopin). Second in line was a natural hormone that is available as an over the counter supplement, melatonin.
While the researchers promoted clonazepam as their first choice, I would have to put my money on melatonin. Not only is it a sleep enhancer, it is a very powerful antioxidant, which means it can not only help with current symptoms, but do that preventive work I mentioned.
One of the biggest problems with the way medicine is practiced, in my opinion, is that we tend to focus on the current problem and what band-aid...er...drug...we can prescribe, to feel like we've fixed the problem. Rarely do we look deeper to the core issue. And that's why so many people are on so many medications today.
I can guarantee you, people with REM sleep disorder are not having problems because their bodies are deficient in clonazepam! But they could be having trouble with melatonin metabolism. Which is why this option makes so much sense to me.
Gugger JJ, Wagner ML. Rapid eye movement sleep behavior disorder. Ann Pharmacother. 2007 Nov;41(11):1833-41.
Bubenik GA, Blask DE, Brown GM, Maestroni GJ, Pang SF, Reiter RJ, ViswanathanM, Zisapel N. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998 jul-Aug;7(4):195-219.
Deigner HP, Haberkorn U, Kinscherf R. Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin Investig Drugs 2000 Apr;9(4):747-64.
Srinivasan V, Pandi Perumal SR, Maestroni GJ, Esquifino AI, Hardeland R, Cardinali DP. Role of melatonin in neurodegenerative diseases. Neurotox Res 2005;7(4):293-318.
Antolin I, Mayo JC, Sainz RM, del Brio Mde L, Herrera F, Martin V, Rodriguez C. Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res 2002 Jul 12;943(2):163-73.
Mayo JC, Sainz RM, Tan DX, Antolin I, Rodriguez C, Reiter RJ. Melatonin and Parkinson's disease. Endocrine 2005 Jul;27(2):169-78.
The New ETLNTA
3 years ago